Skip to content
Boost Up Blog – Lifestyle
Author:
Lir Life Sciences Corp.
LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
June 17, 2026
LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
May 22, 2026
Aya Gold & Silver Reports High-Grade Exploration Drill Results at Boumadine
May 20, 2026
Aya Gold & Silver Reports Q1-2026 Results with Record Revenue and Cash Flow
May 14, 2026
LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
April 28, 2026
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
April 20, 2026